Sagitta Biotech SA

2.1 FTE

Sagitta Biotech reported total assets of 981,671 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Mar 2026), with 2.1 full-time equivalents.

By total assets for 2025, Sagitta Biotech ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0724.569.610 · VAT BE0724569610
4000 Liège
active in Research and experimental development on biotechnology (NACE 72101)
operating since 04 Apr 2019 (≈ 7 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Sagitta Biotech shows with a free account.

See the score
Profile
SA Micro · 2.1 FTE since 2019
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−354,671 €
Equity353,411 €
Cash148,081 €
EBITDA−319,486 €
Total assets981,671 €
Headcount (avg FTE)2.1
The line marks its sector median: 58.2% (260 companies).

Change 2022 → 2025: Total assets +6044 %

Accounts of the company itself (not consolidated).

The full file covers 7 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Sagitta Biotech's annual accounts

20252024202320222021
Net result−354,671 €
Equity353,411 €
Cash148,081 €
EBITDA−319,486 €
Total assets981,671 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 26 Mar 2026
  • Year ended 31 Dec 2024filed on 31 Mar 2025
  • Year ended 31 Dec 2023filed on 03 Apr 2024
  • Year ended 31 Dec 2022filed on 21 Mar 2023
  • Year ended 31 Dec 2021filed on 19 Apr 2022

Sagitta Biotech's financial analysis

Management and control of Sagitta Biotech

6 active director(s) in the register.

Sagitta Biotech's shareholders and holdings →

Sagitta Biotech's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0724.569.610
VAT number
BE0724569610
Peppol
Registered · 0208:0724569610 · as of 10 Nov 2026
Legal form
SA
Incorporated
04 Apr 2019
Registered office
4000 Liège
Size
Micro · 2.1 FTE
Latest accounts
2025 · filed on 26 Mar 2026
Activity
Research and experimental development on biotechnology (NACE 72101)

Sagitta Biotech (SA) has been based in Liège since 2019, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 354,671 € and equity of 353,411 €; its revenue is not published. With 2.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 36.0%, below the median of its sector (58.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Sagitta Biotech

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Sagitta Biotech

What is the revenue of Sagitta Biotech?

Sagitta Biotech files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Sagitta Biotech?

In Belgium, the VAT number is the company number prefixed with BE: BE0724569610 for Sagitta Biotech, if the company is VAT-registered. Its company number (CBE) is 0724.569.610.

Where is the registered office of Sagitta Biotech?

According to the CBE register, the registered office of Sagitta Biotech is in 4000 Liège.

What is the equity of Sagitta Biotech?

At the close of the 2025 financial year, the equity of Sagitta Biotech amounts to 353,411 €, a solvency of 36.0% of total assets.

How many people work at Sagitta Biotech?

2.1 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Sagitta Biotech?

The register lists 6 active mandates at Sagitta Biotech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Sagitta Biotech within its sector?

By total assets for 2025, Sagitta Biotech ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.

Idonis

The full file of Sagitta Biotech

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 19 Sep 2026

No credit card, no commitment.

What each plan unlocks →